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 Cadmium is a highly toxic environmental pollutant that can cause many adverse 
effects including cancer, neurological disease and kidney damage. Aquatic amphibians 
are particularly susceptible to this toxicant as it was shown to cause developmental 
abnormalities and genotoxic effects. In mammalian cells, the accumulation of heme 
oxygenase-1 (HO-1), which catalyzes the breakdown of heme into CO, free iron and 
biliverdin, was reported to protect cells against potentially lethal concentrations of CdCl2. 
In the present study, CdCl2 treatment of A6 kidney epithelial cells, derived from the frog, 
Xenopus laevis, induced the accumulation of HO-1, heat shock protein 70 (HSP70) and 
HSP30 as well as an increase in the production of aggregated protein and aggresome-like 
structures. Treatment of cells with inhibitors of HO-1 enzyme activity, tin protoporphyrin 
(SnPP) and zinc protoporphyrin (ZnPP), enhanced CdCl2-induced actin cytoskeletal 
disorganization and the accumulation of HO-1, HSP70, aggregated protein and 
aggresome-like structures. Treatment of cells with hemin and baicalein, which were 
previously shown to provide cytoprotection against various stresses, induced HO-1 
accumulation in a concentration-dependent manner. Also, treatment of cells with hemin 
and baicalein suppressed CdCl2-induced actin dysregulation and the accumulation of 
aggregated protein and aggresome-like structures. This cytoprotective effect was 
inhibited by SnPP. These results suggest that HO-1-mediated protection against CdCl2 
toxicity includes the maintenance of actin cytoskeletal and microtubular structure and the 
suppression of aggregated protein and aggresome-like structures.  
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Cadmium is a carcinogenic and toxic metal that occurs naturally in the 
environment or as a result of industrial pollution (Waisberg et al., 2003; Joseph, 2009; 
Templeton and Liu, 2010). Continuous exposure to cadmium has been associated with a 
number of disease states including Alzheimer's disease and lung cancer (Mendez-
Armenta and Rios, 2007; Nordberg, 2009; Johri et al., 2010; Templeton and Liu, 2010).  
While many organs and tissues are adversely affected by cadmium, the kidney is 
particularly sensitive to its toxic effects (Waisberg, 2003; Nordberg, 2009; Johri et al., 
2010). Cadmium exposure can result in a number of harmful intracellular effects 
including the production of reactive oxygen species (ROS), damage to DNA and its 
repair system and the formation of denatured and abnormal proteins, which can become 
aggregated and form aggresome-like structures (Waisberg et al., 2003; Bertin and 
Averbeck, 2006; Mouchet et al., 2006; Mendez-Armenta and Rios, 2007; Khan et al., 
2015). Also cadmium exposure can induce the expression of a number of genes which are 
thought to be involved in counteracting its injurious effects including those encoding 
heme oxygenase-1 (HO-1) and heat shock proteins (HSPs; Alam et al., 2000; Ovelgonne 
et al., 1995; Somji et al., 2000; Music et al., 2014). 
HO-1, which is the stress-inducible isozyme of heme oxygenase, catalyzes the 
breakdown of heme into CO, free iron and biliverdin (Platt and Nath, 1998; Hwang et al., 
2009). While HO-1 is an ER protein, it lacks a signal peptide and a KDEL retention 
sequence (Gottlieb et al., 2012). However, HO-1 is posttranslationally inserted into the 
ER membrane via its C-terminal end (Yoshida and Sato, 1989; Gottlieb et al., 2012).  














including mouse, zebrafish, carp, and chicken (Sardana et al., 1982; Alam et al., 2000; 
Blechinger et al., 2007; Jancsó and Hermesz, 2015). Other agents were found to induce 
HO-1 accumulation in mammalian cultured cells including hemin and the plant 
flavonoid, baicalein (Alam et al., 2000; Brouard et al., 2000; Li-Weber, 2009). Cadmium-
, hemin- and baicalein-induced ho-1 gene expression involves the Maf recognition 
elements (MARE)/ nuclear factor-erythroid 2 family member (Nrf2) pathway (Alam et 
al., 2000; Alam and Cook, 2007; Macleod et al., 2009). It has been proposed that 
cadmium-induced ho-1 gene expression may include the cadmium response element 
(CdRE) and the transcription factors HSF1 and pescadillo (Sikorski et al., 2006; Koizumi 
et al., 2007).  
A number of studies in mammalian systems examined the cytoprotective nature of 
HO-1 accumulation (Brouard et al., 2000; Lang et. al., 2004). For example, pretreatment 
of rats with hemin, which upregulated HO-1 levels, protected their kidneys and testes 
against damage by mercury and cadmium, respectively (Yoneya et al., 2000; Fouad et al., 
2009). Baicalein-induced HO-1 accumulation was associated with protection against 
vascular injuries and enhanced survival of human cardiomyocytes in response to 
oxidative challenges (Chen et al., 2006; Cui et al., 2015). HO-1-mediated cytoprotection 
against oxidative stress involves its catalytic breakdown products, CO and bilirubin 
(Gozzelino et al., 2010; Correa-Costa et al., 2012). For example, HO-1-mediated 
production of CO inhibited apoptosis through its interaction with p38 mitogen-activated 
kinase (MAPK; Brouard et al., 2000). Also, bilirubin, a potent antioxidant, protected 
HeLa cells and cultured rat neurons against H2O2-mediated necrotic cell death (Stocker et 














cytoprotection against a variety of stressors was reported to be suppressed in a 
competitive fashion by the HO-1 enzyme activity inhibitors and heme analogs, tin 
protoporphyrin (SnPP) and zinc protoporphyrin (ZnPP; Srisook et al., 2005; Varga et al., 
2007; Miyake et al., 2010; Wong et al., 2011). The addition of SnPP was found to 
sensitize mouse T cells to hypoxia by inhibiting HO-1 enzyme activity while ZnPP 
supressed HO-1-mediated protection against cadmium stress in rat glial cells (Srisook et 
al., 2005; Dey et al., 2014).  
Cadmium has been shown to induce the accumulation of HSPs in a wide range of 
organisms (Heikkila et al., 1982; Ovelgonne et al., 1995; Somji et al., 2000; Blechinger et 
al., 2007; Woolfson and Heikkila, 2009; Selim et al., 2012). HSPs are molecular 
chaperones that were classified primarily by size into families including small HSPs, 
HSP40, HSP60, HSP70, and HSP90 (Morimoto, 2008). Some HSPs are strictly stress-
inducible while others are constitutively expressed or constitutive but responsive to 
induction. HSPs perform a number of roles in maintaining cellular protein homeostasis, 
such as protein folding, preventing aggregation of unfolded proteins and protein 
translocation (Balch et al., 2008). The heat shock response (HSR) involves the 
transcription of hsp genes to counteract stresses that affect cellular protein homeostasis 
such as high temperature, heavy metals or elevated levels of ROS (Heikkila, 2004; 
Voellmy, 2004; Morimoto, 2008; Heikkila, 2010). Under non-stress conditions, 
monomeric heat shock factor-1 (HSF-1) is functionally inactive as it is in a complex with 
HSP90 (Voellmy, 2004; Morimoto, 2008). Stress-induced accumulation of 
unfolded/misfolded protein results in the dissociation of HSP90 from HSF-1, which then 














shock element (HSE) and stimulates the transcription of hsp genes (Voellmy 2004; 
Morimoto 2008). Cadmium treatment of cells, which was found to cause protein damage 
due to oxidative stress or the formation of polydentate coordination complexes with the 
protein backbone resulted in the accumulation of misfolded/damaged protein leading to 
the activation of the HSR (Bharadwaj et al., 1998; Waisberg et al., 2003; Morimoto, 
2008; Galazyn-Sidorczuk et al., 2009; Tamás et al., 2014). 
Aquatic poikilotherms, such as amphibians and fish, are susceptible to the effects 
of cadmium as it can enter dermally through the skin and gills in a concentration-
dependent manner by diffusion or active ion transport (Faurskov and Bjerregaard, 2002). 
During early stages of embryogenesis of the frog, Xenopus laevis, cadmium was 
determined to be especially toxic (Mouchet et al., 2006). Also, treatment of X. laevis A6 
kidney epithelial cells with CdCl2 induced the accumulation of HO-1 and HSPs, 
including HSP70, HSP30, immunoglobulin-binding protein (BiP), and HSP110, as well 
as inhibition of the ubiquitin proteasome system (UPS) and the formation of aggresome-
like inclusion bodies (Voyer and Heikkila, 2008; Woolfson and Heikkila, 2009; Brunt et 
al., 2012; Khamis and Heikkila, 2013; Music et al., 2014; Khan et al., 2015; Heikkila, 
2017; Shirriff and Heikkila, 2017). When the amount of aggregated or unfolded protein 
exceeds the capacity of the UPS machinery to degrade it, the cell transports protein 
aggregates along microtubules using dynein motors to form aggresomes proximal to the 
nucleus (Taylor et al, 2003; An and Statsyuk, 2015). Aggresomes, which are sequestered 
protein aggregates within a vimentin cage, minimize the toxic effects of cellular protein 
aggregates until their proteolysis by autophagy (Bolhuis and Richter-Landsberg, 2010; 














reported to associate with aggresomes and aggresome-like structures, suggesting a role 
for HSPs in their formation (Tyedmers et al., 2010; Katoh et al., 2004; Bolhuis and 
Richter-Landsberg, 2010). Recently, it was reported that CdCl2  treatment of Xenopus A6 
cells caused a co-localization of HSP30 with aggresome-like structures (Khan et al., 
2015). 
Given that CdCl2 treatment of X. laevis A6 cells induced the accumulation of HO-
1, HSPs, aggregated protein and the formation of aggresome-like structures and 
disorganization of the actin cytoskeleton, we were interested in determining whether 
modification of HO-1 enzyme activity could modulate these responses. Initially, we 
investigated the effect of HO-1 enzyme activity inhibitors SnPP and ZnPP on HSP70 and 
HO-1 accumulation and the effect of SnPP on CdCl2-induced production of aggregated 
protein and aggresome-like structures. In the next phase of this research, we examined 
the effects of treating A6 cells with the HO-1 accumulation inducers, hemin and 
baicalein, prior to the addition of CdCl2 to determine whether this treatment regimen 
could ameliorate the toxic effects of this metal. In these latter studies, the actin 
cytoskeleton, microtubular structure and the formation of aggregated protein and 

















2.0 Materials and methods 
2.1 Chemicals 
CdCl2 (Bioshop, Burlington, ON) was prepared as a 100 mM stock solution in 
sterile water (Sigma-Aldrich). Hemin (Sigma-Aldrich, Oakville, ON) was prepared by 
dissolving it in dimethyl sulfoxide (DMSO; Sigma-Aldrich) to yield a 1.5 mM stock 
solution. HO-1 enzyme activity inhibitors, tin protoporphyrin (SnPP; Enzo Life Sciences, 
Farmingdale, NY) and zinc protoporphyrin (ZnPP; Enzo Life Sciences) were dissolved in 
DMSO to produce 1.5 mM stock solutions. Baicalein (Sigma-Aldrich) was also dissolved 
in DMSO to produce a 10 mM stock solution. After stocks were made, hemin, ZnPP, 
SnPP and baicalein were kept wrapped in tin foil to protect them from light prior to 
storage at -20 °C.  
2.2 Culture of X. laevis A6 kidney epithelial cells 
 X. laevis A6 kidney epithelial cells were obtained from the American Type 
Culture Collection (CCL-102; Rockville, MD). Cells were cultured in T75 cm2 flasks 
(VWR, Mississauga, ON) at 22 ºC using 70% L15 (Leibowitz) cell culture media with 
10% fetal bovine serum and 1% penicillin/streptomycin (Sigma-Aldrich). Once the cells 
were confluent, they were rinsed once with 1 ml versene [0.02% (w/v) KCl, (0.8% (w/v) 
NaCl, 0.02% (w/v) KH2PO4, 0.115% (w/v) NaHPO4, 0.02% (w/v) Na2EDTA] and then 
again with 2 ml versene followed by treatment with 1 ml of 1X trypsin (Sigma-Aldrich) 
in Hank's balanced salt solution (HBSS, Sigma-Aldrich) to facilitate cell detachment. 
Fresh media was then added to resuspend cells and inactivate trypsin followed by transfer 














2.3 Cell treatments 
Chemical treatments were administered to cells at 80-90% confluency. In 
experiments using 25 to 275 µM CdCl2, 10 to 30 µM hemin or 50 to 400 µM baicalein, 
these chemicals were mixed with L-15 media and administered to the cells at the final 
concentration described. In experiments examining HO-1 enzyme activity inhibitor 
effects on cadmium-treated cells, cells were treated with ZnPP or SnPP for 4 h prior to 
supplementation with CdCl2 for 16 h at 22 °C. Finally, cytoprotection studies involved 
the incubation of cells with baicalein or hemin and/or SnPP for 4 h prior to 
supplementation with CdCl2 for 16 h, followed by a 4 h recovery in fresh media. 
2.4 Protein isolation and quantification  
 Prior to collection, cells were rinsed once with 2 ml of 65% HBSS and then 
resuspended in 1 ml 100% HBSS. Cells were transferred to 1.5 ml microcentrifuge tubes 
(Eppendorf centrifuge; Model No. 5810R; Mississauga, ON) and collected by 
centrifugation at 14,000 rpm for 1 min and then stored at -80 °C. For protein isolation, 
cells were lysed using 300 µL of 1% SDS lysis buffer (200 mM sucrose, 2 mM EGTA, 1 
mM EDTA, 40 mM NaCl, 30 mM HEPES, pH 7.4, 1% protease inhibitor and 1% SDS) 
followed by sonication on ice with a sonic dismembranator (Model 100, Fisher Scientific; 
Waltham, MA, USA). Cell debris and unlysed cells were separated from the protein 
isolate by centrifugation at 14,000 rpm for 60 min at 4 °C. Protein content of the 
supernatant was quantified by the bicinchoninic acid protein quantification assay kit 
(Pierce, Rockford, IL, USA). Protein standards were made by diluting a bovine serum 
albumin (BSA; Bioshop) solution with MilliQ water to final concentrations ranging from 














well plate followed by the addition of the assay reagents. The plate was then incubated at 
37 °C for 30 min and monitored at 562 nm using a Versamax Tunable microplate reader 
(Molecular Devices, Sunnyvale, CA, USA) and Softmax Pro software.  
2.5 SDS-PAGE and immunoblot analysis 
 Protein samples were separated by sodium dodecyl-sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) using 12% acrylamide gels as previously described (Young 
and Heikkila, 2010). Protein was transferred from acrylamide gels to nitrocellulose 
membranes using a Trans-Blot Semi-dry transfer system (Bio-Rad, Mississauga, ON) for 
25 min at 20 V. Transfer efficiency was assessed by protein staining with Ponceau S 
(Sigma-Aldrich). Blots were incubated for 1 h in 5% skim milk (Carnation, Markham 
ON) in Tris buffered saline (20 mM Tris pH 7.5, 300 mM NaCl) with 0.1% Tween-20 
(TBS-T; Sigma-Aldrich) to inhibit non-specific protein binding. The membranes were 
incubated with rabbit anti-HO-1 (1:500; Enzo Life Sciences; Catalog no. BML-HC3001-
100), anti-Xenopus HSP70 (1:350; Gauley et al., 2008), anti-Xenopus HSP30 (1:500; 
Fernando and Heikkila, 2000), or anti-actin (1:200; Sigma; Catalog no. A2066) 
polyclonal antibodies diluted in 5% skim milk solution and left overnight. Membranes 
were then washed with TBS-T once for 15 min and then twice for 10 min each followed 
by incubation with alkaline phosphatase-conjugated goat-anti-rabbit IgG antibodies 
(BioRad) in TBS-T with 5% blocking for 1 h at 22 °C. Membranes were rinsed with 
TBS-T for 15 min followed by two 5 min rinses. Bands were then visualized by 
incubating blots in alkaline phosphatase detection buffer (100 mM Tris pH 9.5, 100 mM 
NaCl, 50 mM MgCl2) with 0.3% nitro blue tetrazolium (Roche) and 0.17% 5-bromo-4-















 Densitometric analysis of immunoblots was performed, within the range of 
linearity, using Image J software (Version 1.49; National Institute of Health; 
http://rsb.info.nih.gov/ij/) to quantify band intensity. The band intensity of each sample 
was expressed as a percentage of the maximum value for HO-1, HSP70, or HSP30 in a 
particular trial. The percentages for a given treatment were averaged across three 
replicates and graphed. Standard error of the mean was indicated as vertical error bars. 
Significance (p < 0.05%) between control and treatment intensity was determined using 
one-way ANOVA with Tukey's post hoc test.  
2.7 Immunocytochemistry and laser scanning confocal microscopy (LSCM) 
 Cells for laser scanning confocal microscopy imaging were grown on flame 
sterilized base-washed coverslips (VWR; Catalog no. 48366-067) in Petri dishes (VWR, 
Catalog no. 351029). Following various treatments (see Section 2.3), coverslips were 
rinsed with phosphate-buffered saline supplemented with magnesium and calcium (PBS; 
1.37 M NaCl, 67 mM Na2HPO4, 26 mM KCl, 14.7 mM H2PO4, 1 mM CaCl2, 0.5 mM 
MgCl2 pH 7.4). Coverslips were then transferred to small Petri dishes and fixed with 
3.7% paraformaldehyde (BDH Inc., Toronto, ON) in PBS for 15 min followed by three 
further washes for 5 min each and then permeabilized with 0.3% Triton X-100 (TX-100; 
Sigma-Aldrich) in PBS for 10 min. Coverslips were washed 3 times with PBS for 2 min 
each and then incubated in 3.7% BSA in PBS overnight at 4 °C. They were then 
incubated with dilutions of rabbit anti-HO-1, 1:500 anti-HSP30 or 1:250 anti-α-tubulin 
antibody (Sigma, Catalog no. T9026) in PBS w/ 3.7% BSA solution for 1 h at 22 °C. 














1:2,000 dilution of fluorescent-conjugated goat anti-rabbit IgG or goat anti-mouse IgG 
Alexa Fluor 488 secondary antibodies (Invitrogen Molecular Probes, Carlsburg, CA) in 
PBS with 3.7% BSA for 30 min followed by 3 washes with PBS. For actin visualization, 
coverslips were incubated in PBS with 3.7% BSA containing a 1:60 dilution of 
rhodamine-tetramethylrhodamine-5-isothiocyanate phalloidin (TRITC; Invitrogen 
Molecular Probes) for 15 min in the dark. The Proteostat aggresome detection kit (Enzo 
Life Sciences, Plymouth Meeting, PA, USA) was used to detect the presence of 
aggregated protein and/or aggresome-like structures according to the manufacturer's 
instructions. The cover slips were dried and then mounted on glass slides using 
Vectashield mounting medium (Vector Laboratories, Burlingame CA) containing 4, 6-
diamidino-2-phenylindole (DAPI). Slides were sealed using clear nail polish and stored at 
4 °C until viewed using a Zeiss Axiovert 200 confocal microscope with LSM 510 META 

















3.1 Pattern of HO-1, HSP70, HSP30 and aggregated protein/aggresome-like structure 
accumulation in cells treated with CdCl2  
This study examined the effect of different concentrations of CdCl2 on HO-1, 
HSP70 and HSP30 accumulation in X. laevis A6 cells by immunoblot and subsequent 
densitometric analysis. As shown in Fig. 1A, treatment of cells with 200 μM CdCl2  
showed the highest levels of HO-1 accumulation. Cells treated with 25, 50 or 100 μM 
CdCl2 resulted in HO-1 levels that were 18%, 48% and 88%, respectively, of levels 
attained at 200 M. Also, CdCl2 treatment induced HSP30 and HSP70 accumulation at 25 
μM and 100 μM CdCl2, respectively, with the highest levels of both HSPs at 200 μM. 
Finally, the relative levels of actin remained constant in cells treated with different 
concentrations of CdCl2. As shown in Fig. 1B and C, treatment of cells with 200 μM 
CdCl2 resulted in the accumulation of HO-1 and HSP30 in granular patterns in the 
perinuclear region. Some larger HSP30 complexes were also observed in the cytoplasm 
near the nucleus (indicated with white arrows). HSP70 was not examined by 
immunocytochemistry because the affinity-purified anti-Xenopus HSP70 antibody, which 
was used successfully in immunoblot analysis, did not specifically detect HSP70 by 
immunocytochemistry (Gauley et al., 2008; Khan and Heikkila, 2014). CdCl2 treatment 
resulted in disorganization of actin fibres and membrane ruffling. Finally, incubation of 
cells with 200 μM CdCl2 resulted in some microtubule filament disorganization and the 
accumulation of aggregated protein primarily in the perinuclear region in a granular 
fashion (Fig. 1D). Large aggresome-like structures, as indicated by the white arrows, 














3.2 Effect of HO-1 enzyme activity inhibitors on CdCl2-induced accumulation of HO-1, 
HSP70 and aggregated protein/aggresome-like structures. 
 Since CdCl2 treatment of A6 cells enhanced the accumulation of HO-1 and 
HSP70, it was of interest to determine whether treatment with the HO-1 enzyme activity 
inhibitors, tin protoporphyrin (SnPP) and zinc protoporphyrin (ZnPP), could modify the 
effects of CdCl2. As shown in Fig. 2, the presence of either 5 μM ZnPP or 15 μM SnPP 
enhanced 50 μM CdCl2-induced accumulation of HO-1 compared to CdCl2 alone. 
Densitometric analysis determined that the relative level of HO-1 found with SnPP or 
ZnPP was not statistically different from control levels. The HO-1 level in cells treated 
with 50 μM CdCl2 was present at 45% of maximum levels whereas the mean relative 
density of SnPP and ZnPP plus CdCl2 was 90% and 80%, respectively. Enhancement of 
CdCl2-induced HO-1 accumulation was also observed using immunocytochemistry (data 
not shown). While the HO-1 enzyme activity inhibitors induced very low levels of 
HSP70 accumulation and 50 μM CdCl2 induced only a slight increase in HSP70 levels 
relative to control, treatment with ZnPP or SnPP plus CdCl2 resulted in significant 
increases in HSP70 accumulation.  
Given that treatment of A6 cells with HO-1 enzyme activity inhibitors enhanced 
CdCl2-induced accumulation of both HO-1 and HSP70, we examined the effect of SnPP 
plus CdCl2 on actin cytoskeletal, microtubular structure and the presence of aggregated 
protein. As shown in Fig. 3, actin stress fibres and the pattern of microtubules in cells 
treated with SnPP or 100 μM CdCl2 resembled those of control cells. In cells treated with 
SnPP prior to supplementation with CdCl2, there was noticeable membrane ruffling and 














tangled compared to control. As indicated in Fig. 3, cells treated with 15 μM SnPP 
resulted in minimal accumulation of aggregated protein, as determined by Proteostat dye 
staining, that was similar to control cells. An increase in aggregated protein in the 
perinuclear region was detected in cells treated with 100 μM CdCl2. However, this 
accumulation of aggregated protein was enhanced in cells treated with SnPP prior to 
supplementation with CdCl2. Furthermore, these cells were characterized by the presence 
of larger, aggresome-like staining structures, as indicated by white arrows. Similar results 
were observed using ZnPP (data not shown).  
3.3 Pattern of HO-1 accumulation in cells treated with hemin or baicalein  
 Since HO-1 enzyme activity inhibitors enhanced the levels of CdCl2-induced 
aggregated protein and aggresome-like structures, we examined the effect of hemin and 
baicalein, which are known HO-1 inducers in mammalian cells, on CdCl2-treated cells 
(Salahudeen et al., 2001; Srisook et al., 2005; Fouad et al., 2009; Gozzelino et al., 2010; 
Cui et al., 2015). Since the effects of hemin and baicalein on HO-1 accumulation had not 
been investigated in amphibians, initially we examined the effect of different 
concentrations of these agents on HO-1 accumulation in A6 cells by immunoblot and 
subsequent densitometric analysis. As shown in Fig. 4A, maximal levels of HO-1 
occurred in cells incubated for 16 h with 25 μM hemin. Densitometric analysis revealed 
that while control cells had very low levels of HO-1, cells treated with 10, 15, 20 and 30 
μM hemin displayed HO-1 levels that were 65%, 83%, 90%, and 94%, respectively, of 
the value obtained with 25 μM hemin (Fig. 4A). In cells treated with baicalein for 16 h, 
elevated levels of HO-1 were observed at 50 μM and 100 μM with peak levels at 200 μM 














HSP70 and HSP30 accumulation was not detected in response to hemin or baicalein 
treatment (data not shown). Finally, the relative levels of actin remained constant in cells 
treated with different concentrations of hemin and baicalein. Also, hemin- and baicalein-
induced accumulation of HO-1 in A6 cells were the result of de novo synthesis since 
pretreatment of cells with actinomycin D or cycloheximide inhibited HO-1 induction 
(data not shown).  
3.4 Analysis of HO-1 localization in hemin- and baicalein-treated cells. 
Immunocytochemical analysis was employed to examine the intracellular 
localization of HO-1 in response to hemin and baicalein and treatment (Fig. 5). In control 
cells, HO-1 was either not detectable or present at relatively low levels. Cells treated with 
25 μM hemin or 200 μM baicalein showed an intense accumulation of HO-1. In response 
to each of these stressors, HO-1 accumulation was present in the perinuclear region in a 
punctate pattern with some staining in the nucleus. Actin filaments, as detected using 
phalloidin staining, revealed a slight disorganization in A6 cells treated with hemin or 
baicalein (Fig. 5). In other experiments, microtubule structure was not markedly affected 
by 25 μM hemin or 200 μM baicalein treatment (data not shown).  
3.5 Effect of hemin and baicalein treatment on CdCl2-induced HO-1 accumulation and 
actin cytoskeletal structure.  
 As mentioned previously, various studies reported that treatment of cells with 
hemin or baicalein have the potential to ameliorate the deleterious effects of potentially 
toxic conditions including CdCl2 exposure (Srisook et al., 2005; Fouad et al., 2009;). 














A6 cells from a relatively high and lethal concentration of CdCl2. As shown in Fig. 6 and 
7, treatment of cells with 10 μM hemin or 50 μM baicalein for 16 h had no discernable 
effect on the actin cytoskeleton whereas exposure of cells to 275 μM CdCl2 resulted in 
actin cytoskeletal disorganization including cell rounding, membrane ruffling and/or 
cytoskeletal collapse. However, treatment of cells with hemin or baicalein prior to the 
addition of CdCl2 resulted in the presence of control-like actin stress fibres although some 
membrane ruffling persisted at the cell periphery. In these latter experiments, the 
inclusion of SnPP eliminated the cytoprotective effect against CdCl2 provided by hemin 
or baicalein. Cells treated with SnPP prior to the addition of CdCl2 showed a severe 
disruption of the actin cytoskeleton (data not shown). Also, elevated levels of HO-1 were 
observed in the perinuclear region of cells treated with hemin or baicalein prior to the 
addition of CdCl2 in contrast to the lower levels of HO-1 found with hemin, baicalein, 
CdCl2 or SnPP alone (Fig. 6 and 7). 
3.6 Effect of hemin and baicalein treatment on CdCl2-induced aggregated protein and 
aggresome-like structures.  
 In the next series of experiments, we examined the effect of treating A6 cells with 
hemin or baicalein prior to the addition of CdCl2 on the accumulation of aggregated 
protein (Fig. 8 and 9). Treatment of cells with 275 μM CdCl2 induced perinuclear 
accumulation of aggregated protein as well as the presence of large aggresome-like 
staining structures. However, exposure of cells to 10 μM hemin or 50 μM baicalein 
followed by supplementation with CdCl2 resulted in diminished amounts of both diffuse 
and perinuclear aggregated protein and aggresome-like staining structures. When cells 














protein and aggresome-like structures were observed. In an examination of microtubule 
structure, treatment with 275 μM CdCl2 resulted in some disorganization and intertwining 
of microtubules. This effect was mitigated in cells treated with hemin or baicalein prior to 
CdCl2 addition as they had more elongated, parallel microtubules compared to CdCl2 
alone. In cells that were treated with SnPP and hemin prior to supplementation with 
CdCl2, the microtubules had a mesh-like appearance.   
 Previously, our laboratory reported that CdCl2-induced aggresome-like structures 
that co-localized with the small HSP, HSP30 (Khan et al., 2015). Given these earlier 
results, HSP30 localization was examined in the current study. As shown in Figs. 10 and 
11, cells treated with CdCl2 alone displayed the accumulation of HSP30 in a punctate 
pattern with larger staining structures, as indicated by the white arrows. These larger anti-
HSP30 antibody stained structures co-localized with the aggresome-like structures 
(detected by the Proteostat dye) given their yellow color in the merged channel. This 
finding was verified by means of Z-stack analysis (data not shown). In cells treated with 
hemin or baicalein prior to supplementation with CdCl2, the amount of aggregated 
protein was reduced compared to CdCl2 alone whereas the amount of HSP30 
accumulation in some cells was elevated and had a more diffuse pattern of cytoplasmic 
distribution and fewer larger structures. Addition of SnPP plus hemin or baicalein prior to 
CdCl2 treatment resulted in cells having a pattern of HSP30 accumulation similar to 

















In this study, treatment of X. laevis A6 cells with CdCl2 induced the accumulation 
of HO-1, HSP70 and HSP30. Induction of HO-1 and HSPs by cadmium has been 
documented across a wide range of organisms including amphibians, fish, and mammals 
(Heikkila et al., 1982; Sardana et al., 1982; Woolfson and Heikkila, 2009; Søfteland et 
al., 2010; Khamis and Heikkila, 2013; Music et al., 2014; Shirriff and Heikkila, 2017). It 
has been suggested that CdCl2-induced HO-1 accumulation involves cadmium-mediated 
generation of ROS and disruption of Nrf2/Keap1 association causing Nrf2 stabilization 
and permitting its binding to MARE and subsequent transcription of the ho-1 gene (Alam 
et al., 2000; Ryter et al., 2006). Treatment of cells with CdCl2 can also trigger the HSR 
leading to the expression of hsp genes due to an increase in unfolded proteins resulting 
from cadmium-induced oxidative damage, reaction with vicinal thiol groups or 
substitution for zinc in proteins (Bharadwaj et al., 1998; Waisberg et al., 2003; Voellmy, 
2004; Morimoto 2008; Galazyn-Sidorczuk et al., 2009; Heikkila, 2010; Tamás et al., 
2014). Interestingly, treatment of A6 cells with HO-1 enzyme activity inhibitors, SnPP 
and ZnPP, enhanced the levels of CdCl2-induced HO-1 and HSP70. It is possible that 
treatment of A6 cells with SnPP or ZnPP enhanced the ROS-generating effects of CdCl2. 
Previously it was reported that HO-1 levels and ROS production in cadmium-treated liver 
cells were significantly enhanced by the addition of HO-1 enzyme activity inhibitors 
(Lawal et al., 2015). Also, ZnPP treatment increased the oxidative stress-mediated 
induction of HO-1 accumulation and the cytotoxicity of the chemotherapeutic agent, 
gemcitabine, in human prostate cells (Varga et al., 2007). While the effect of HO-1 














organisms, these agents may have caused an increase in CdCl2-induced protein damage 
or unfolding leading to a more dynamic HSR resulting in an elevated level of HSP70. 
Support for this latter possibility was indicated by the enhanced amounts of aggregated 
protein and aggresome-like structures that were detected in A6 cells treated with 100 μM 
CdCl2 and SnPP compared to CdCl2 alone.  
Treatment of A6 cells with cadmium plus SnPP also induced the disorganization 
of the actin cytoskeleton and microtubular structure to an extent that was greater than 
observed with CdCl2 alone. Previous studies reported that cadmium treatment caused the 
disruption of the actin cytoskeleton and/or the disassembly or destruction of microtubules 
in various cell lines including carp hepatocyte, rat renal proximal tubule and mouse 3T3 
cells (Perrino and Chou, 1986; Wang et al., 1996; Nawaz et al., 2005). It was suggested 
in these studies that the dysregulation of the actin cytoskeleton and microtubule network 
may be caused, in part, by CdCl2-induced oxidative stress. Treatment of mammalian cells 
with CdCl2 or oxidative stress can cause actin fragmentation and depolymerisation (Huot 
et al., 1996; Wang et al., 1996). It is likely that treatment of A6 cells with SnPP/ZnPP and 
CdCl2 caused an increase in ROS-induced damage to proteins associated with the actin 
cytoskeleton and microtubular network (Galazyn-Sidorczuk et al., 2009; Tamás et al., 
2014).  
The next phase of this research examined the effect of the HO-1 inducers, hemin 
and baicalein, on CdCl2-treated A6 cells. Given the lack of information regarding the 
effects of hemin and baicalein in Xenopus, initial analysis examined their effect on HO-1 
accumulation. In A6 cells, both hemin and baicalein induced a dose-dependent 














animal systems (Salahudeen et al., 2001; Lang et al., 2004; Chen et al., 2006; Lin et al., 
2007; Zhang et al., 2012; Choi et al., 2016). The finding that actinomycin D and 
cycloheximide inhibited hemin- and baicalein-induced HO-1 in A6 cells indicated the 
involvement of de novo transcription and translation. In mammalian cells, it was reported 
that heme can bind directly to the repressor protein, Bach1, causing it to detach from the 
MARE site and permitting the binding of Nrf2 (Ogawa et al., 2001; Zenke-Kawasaki, 
2007). Other studies suggested that baicalein directly modified cysteine residues in Keap-
1 causing its disassociation from Nrf2 resulting in increased Nrf2 stabilization and 
subsequent ho-1 gene expression (Zhang et al., 2012, Cui et al., 2014). In A6 cells, it is 
tenable that the aforementioned mechanisms are involved in hemin- and baicalein-
induced accumulation of HO-1.  
The finding that hemin and baicalein induced HO-1 accumulation in A6 cells in a 
punctate pattern with enrichment in the perinuclear region was in agreement with 
mammalian studies (Yoshida and Sato, 1989; Gottlieb et al., 2012). Perinuclear 
localization of HO-1 in Xenopus A6 cells was also found after treatment with CdCl2, 
sodium arsenite, MG132 and isothiocyanates (Music et al, 2014; Khamis and Heikkila, 
2018). In some A6 cells, hemin- and baicalein-induced HO-1 accumulation was found in 
the nucleus. Studies in mammalian cells determined that HO-1, which is anchored to the 
ER by a C-terminal transmembrane region such that it faced the cytosol, could be cleaved 
from its ER anchor and undergo translocation to the nucleus (Converso et al., 2006; Lin 
et al., 2007; Sacca et al., 2007; Namba et al., 2014). The punctate pattern of hemin- or 
baicalein-induced HO-1 accumulation in A6 cells may be the result of HO-1 














order complexes containing biliverdin reductase (Huber et al., 2009; Linnenbaum et al., 
2012).   
Treatment of A6 cells with hemin and baicalein were able to mitigate the effects 
of 275 μM CdCl2 on actin cytoskeletal structure. These findings suggested that the 
cytoprotection conferred by hemin and baicalein may have been mediated by HO-1 since 
the protective effects were inhibited by SnPP. In other studies, hemin-induced protection 
of rats against cadmium-induced testicular damage was suppressed by SnPP (Fouad et al., 
2009). Also, elevated levels of HO-1 induced by NO protected rat glial cells from the 
toxic effects of CdCl2-induced oxidative stress (Srisook et al., 2005). While the effect of 
baicalein-induced protection from the effect of CdCl2 has not been examined in other 
systems, baicalein-mediated HO-1 accumulation was shown to provide cytoprotection 
against oxidative stress (Chen et al., 2006; Lin et al., 2007; Choi et al., 2010; Cui et al., 
2015).  
In A6 cells, hemin and baicalein treatment prior to the addition of 275 μM CdCl2 
reduced the level of accumulation of aggregated protein and aggresome-like structures 
compared to CdCl2 alone. Furthermore, the addition of SnPP suppressed these effects, 
which indicated that HO-1 enzyme activity may be involved in reducing CdCl2-induced 
proteotoxic stress. As stated earlier, cadmium-induced protein unfolding was the result of 
oxidative stress and interaction of cadmium ions with the protein backbone and thiol-
containing residues (Galazyn-Sidorczuk et al., 2009; Tamás et al., 2014). As mentioned 
previously, HO-1 enzyme activity may counteract cadmium-induced oxidative stress 
through the production of bilirubin, an antioxidant which was shown to reduce ROS 














may also inhibit protein aggregation directly. For example, hemin was shown to non-
specifically inhibit in vitro amyloid fibril-type aggregation of a variety of proteins, 
including alpha-synuclein, alcohol dehydrogenase, catalase, gamma-s-crystallin and beta-
amyloid as well as disaggregating pre-existing fibrils (Liu et al, 2014; Hayden et al., 
2015; Sonavane et al., 2017). Also, baicalein was reported to inhibit the aggregation of 
various proteins in vitro including alpha-synuclein, 1SS-alpha-lacalbumin and lysozyme 
(Zhu et al., 2004; Bomhoff et al., 2006; Kostka et al., 2007). Also, in mouse 
neuroblastoma cells, baicalein treatment was found to reduce alpha-synuclein fibril 
formation (Jiang et al., 2010). Therefore, it is possible that hemin and baicalein may 
inhibit protein aggregation directly in addition to reducing ROS levels through the 
expression of ho-1 genes.  
 In summary, this study has shown, for the first time in amphibians, that HO-1-
mediated protection against CdCl2 toxicity includes not only the maintenance of actin 
cytoskeletal and microtubular structure but also the suppression of aggregated protein and 
aggresome-like structures. It is likely that the primary role of HO-1 and its metabolic 
products, CO and biliverdin, in this situation may be to reduce CdCl2-induced ROS 
levels. A reduction in intracellular ROS could lower the amount of unfolded and/or 
damaged protein and the accumulation of aggregated protein and aggresome-like 
structures. Given that aquatic frogs are particularly sensitive to cadmium, future studies 
will examine the involvement of HO-1 in counteracting cadmium-induced toxicity during 
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Figure 1. Effect of CdCl2 on HO-1, HSP, protein aggregation and aggresome-like 
structure accumulation in A6 cells. A) Cells were maintained at 22 °C (C) or treated with 
25, 50, 100 or 200 μM of CdCl2 (Cd) for 16 h at 22 °C. Proteins were isolated and used 
to generate immunoblots using anti-HO-1, anti-HSP70, anti-HSP30 and anti-actin 
antibodies as described in Materials and methods (representative immunoblots are 
shown). In densitometric analysis, the results were expressed as % mean relative density 
in comparison to the maximum band density obtained for each protein, which was 200 
μM CdCl2 for HO-1, HSP70 and HSP30. Standard error was indicated by the vertical 
bars. A one-way ANOVA and a Tukey’s post-hoc test was used to determine 
significance (p < 0.05), as represented by an asterisk, between control cells and treated 
cells. These data are representative of 3 separate experiments. Immunocytochemical 
analysis was employed to examine the effect of CdCl2 on the localization HO-1, HSP30, 
aggregated protein and aggresome-like structures. Cells, which were cultured on glass 
coverslips, were incubated in media (C) or media supplemented with 200 µM CdCl2 (Cd) 
for 16 h at 22 °C. Nuclei and actin filaments were stained directly using DAPI (blue) and 
rhodamine phalloidin (red), respectively (panels B and C). HO-1 was detected with an 
anti-HO-1 antibody and the secondary antibody conjugate, Alexa-488 fluorophore 
(green; panel B). Rabbit anti-HSP30 IgG antibody and an anti-rabbit IgG antibody 
conjugated to an Alexa-488 fluorophore were used to detect HSP30 (green; panel C). In 














mouse IgG antibody conjugated to an Alexa-488 fluorophore (green). Aggregated 
protein and aggresome-like structures were detected using Proteostat dye (red). White 
arrows indicate aggresome-like structures. White 10 μm scale bars are indicated in the 
lower right of each panel. These data are representative of 3 separate trials. 
Figure 2. Effect of SnPP or ZnPP treatment on 50 µM CdCl2-induced HO-1 and HSP70 
accumulation. A) Cells were maintained at 22 °C (C) or treated with or without a 5 μM 
ZnPP or 15 μM SnPP 4 h treatment prior to supplementation with 50 µM CdCl2 for 16 h 
at 22 °C. Immunoblot analysis of isolated proteins employed anti-HO-1, anti HSP70 and 
anti-actin antibodies. B) Densitometric analysis of HO-1 (black bars) and HSP70 (grey 
bars) accumulation. The results were expressed as % mean relative density as indicated 
in the legend of Figure 3. The error bars indicate standard error of the mean while the 
significance (p < 0.05) compared to control was determined by the one-way ANOVA 
test and Tukey’s post-hoc test and represented by an asterisk. These data are 
representative of 3 separate experiments. 
Figure 3. Effect of SnPP treatment on CdCl2-induced aggregated protein and aggresome-
like structure accumulation. Cells were left untreated (C) or incubated with 100 µM 
CdCl2 (Cd) for 16 h. Also, some cells were treated for 4 h with 15 μM SnPP and then 
incubated with or without the addition of 100 μM CdCl2 for 16 h. Actin filaments were 
stained directly using rhodamine phalloidin (red). -tubulin was detected using a mouse 
anti--tubulin IgG antibody and an anti-mouse IgG antibody conjugated to an Alexa-488 
fluorophore (green) while nuclei were stained with DAPI (blue). Aggregated protein and 














indicate the presence of aggresome-like structures. White 10 μm scale bars are indicated 
in the lower right of each panel. These data are representative of 3 separate trials. 
Figure 4. Effect of different concentrations of hemin and baicalein on HO-1 
accumulation. A) Cells were maintained at 22 °C (C) or treated with either 10, 15, 20, 25 
or 30 μM of hemin or 50 μM of CdCl2 for 16 h at 22 °C. In panel B, cells were incubated 
with 50, 100, 200 or 400 μM baicalein for 16 h at 22 °C. Proteins were isolated and used 
to generate immunoblots using anti-HO-1 and anti-actin antibodies as described in 
Materials and methods (representative immunoblots are shown). In densitometric 
analysis of HO-1, the results were expressed as % mean relative density in comparison to 
the maximum band density obtained for each protein, which were 25 μM and 200 μM for 
hemin and baicalein, respectively. Standard error was indicated by the vertical bars. A 
one-way ANOVA and a Tukey’s post-hoc test was used to determine significance (p < 
0.05), as represented by an asterisk, between control cells and treated cells. These data 
are representative of 3 separate experiments. 
Figure 5. Effect of hemin and baicalein on localization of HO-1. Cells were cultured on 
glass coverslips for 16 h at 22 °C. Cells were left untreated (C) or incubated with 25 μM 
hemin (HM) or 200 μM baicalein (BC). HO-1 was detected with an anti-HO-1 antibody 
and the secondary antibody conjugate, Alexa-488 fluorophore (green). Nuclei and actin 
filaments were stained directly using DAPI (blue) and rhodamine phalloidin (red), 
respectively. White 10 μm scale bars are indicated in the lower right corner of each panel. 
These results are representative of at least 3 separate experiments. 
Figure 6. Effect of hemin treatment on Cd-induced HO-1 localization and actin 














at 22 °C. In other experiments, cells were treated for 4 h with 10 μM hemin (HM) and 15 
μM SnPP prior to being supplemented with 275 µM CdCl2. Nuclei and actin filaments 
were stained directly using DAPI (blue) and rhodamine phalloidin (red), respectively. 
HO-1 was detected with an anti-HO-1 antibody and the secondary antibody conjugate, 
Alexa-488 fluorophore (green). White 10 μm scale bars are indicated in the lower right of 
each panel. These data are representative of 3 separate experiments. 
Figure 7. Effect of baicalein treatment on Cd-induced HO-1 localization and actin 
organization. Cells were left untreated (C) or incubated for 16 h with 275 µM CdCl2 (Cd) 
followed by a 4 h recovery in fresh media. In other experiments, cells were treated for 4 h 
with 50 μM baicalein (BC) and 15 μM SnPP before supplementation with 275 µM CdCl2 
followed by a 4 h recovery in fresh media. Nuclei and actin filaments were stained 
directly using DAPI (blue) and rhodamine phalloidin (red), respectively. HO-1 was 
detected with an anti-HO-1 antibody and the secondary antibody conjugate, Alexa-488 
fluorophore (green). White 10 μm scale bars are indicated in the lower right of each 
panel. These data are representative of 3 separate trials. 
Figure 8. Effect of hemin treatment on Cd-induced aggregated protein and microtubular 
organization. Cells were left untreated (C) or incubated with 275 µM CdCl2 (Cd) for 16 h 
followed by a 4 h recovery in fresh media. Other treatments included incubation of cells 
with 10 μM hemin (HM) and 15 μM SnPP for 4 h prior to supplementation with 275 µM 
CdCl2 for 16 h followed by a 4 h recovery in fresh media. -tubulin was detected using a 
mouse anti--tubulin IgG antibody and an anti-mouse IgG antibody conjugated to an 
Alexa-488 fluorophore (green). Aggregated protein and aggresome-like structures were 














aggresome-like structures. White 10 μm scale bars are indicated in the lower right of each 
panel. These data are representative of 3 separate experiments. 
Figure 9. Effect of baicalein treatment on Cd-induced aggregated protein and 
microtubular organization. Cells were left untreated (C) or incubated with 275 µM CdCl2 
(Cd) for 16 h followed by a 4 h recovery in fresh media. Other treatments included 
incubation of cells with 50 μM baicalein (BC) and 15 μM SnPP for 4 h prior to 
supplementation with 275 µM CdCl2 for 16 h followed by a 4 h recovery in fresh media. 
-tubulin was detected using a mouse anti--tubulin IgG antibody and an anti-mouse IgG 
antibody conjugated to an Alexa-488 fluorophore (green). Aggregated protein and 
aggresome-like structures were detected using the Proteostat dye (red). White arrows 
indicate aggresome-like structures. White 10 μm scale bars are indicated in the lower 
right of each panel. These data are representative of 3 separate trials. 
Figure 10. Effect of hemin treatment on Cd-induced HSP30 and aggregated protein and 
aggresome-like structures. Cells were left untreated (C) or incubated with 275 µM CdCl2 
(Cd) for 16 h followed by a 4 h recovery in fresh media. Other treatments included 
incubation of cells with 10 μM hemin (HM) and 15 μM SnPP for 4 h prior to 
supplementation with 275 µM CdCl2 for 16 h followed by a 4 h recovery in fresh media. 
Rabbit anti-HSP30 IgG antibody and an anti-rabbit IgG antibody conjugated to an Alexa-
488 fluorophore were used to detect HSP30 (green). Aggregated protein and aggresome-
like structures (white arrows) was detected by means of the Proteostat dye. White 10 μm 
scale bars are indicated in the lower right of each panel. These data are representative of 














Figure 11. Effect of baicalein treatment on Cd-induced HSP30 and aggregated protein 
and aggresome-like structure accumulation. Cells were left untreated (C) or incubated 
with 275 µM CdCl2 (Cd) for 16 h followed by a 4 h recovery in fresh media. Other 
treatments included incubation of cells with 50 μM baicalein (BC) and 15 μM SnPP for 4 
h prior to supplementation with 275 µM CdCl2 for 16 h followed by a 4 h recovery in 
fresh media. Rabbit anti-HSP30 IgG antibody and an anti-rabbit IgG antibody conjugated 
to an Alexa-488 fluorophore were used to detect HSP30 (green). Aggregated protein and 
aggresome-like structures were detected using Proteostat dye (red). White arrows indicate 
aggresome-like structures. White 10 μm scale bars are indicated in the lower right of each 
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